acute myeloid leukemia

Showing NaN - NaN of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • +3 more
  • Gilbert, Arizona
  • +14 more
Apr 20, 2022

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Acute Myeloid Leukemia Trial in Australia, Germany, United States (AMG 673)

Terminated
  • Acute Myeloid Leukemia
  • AMG 673
  • Birmingham, Alabama
  • +6 more
Mar 17, 2022

Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)

Terminated
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +137 more
Mar 9, 2022

Acute Myeloid Leukemia, Relapsed Adult AML Trial in United States (Lintuzumab-Ac225, Venetoclax, Spironolactone)

Recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • Los Angeles, California
  • +4 more
Feb 22, 2022

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Myeloid Leukemia Trial in United States (SL-401)

Terminated
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +6 more
Jan 13, 2022

Acute Myeloid Leukemia Trial in Houston, Seattle, Seoul (CWP232291)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
  • +4 more
Dec 9, 2021

Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

Terminated
  • Acute Myeloid Leukemia
  • +4 more
  • Aldesleukin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 15, 2021

Acute Myeloid Leukemia Trial in United States (AMV564, AMV564 in combination with pembrolizumab)

Completed
  • Acute Myeloid Leukemia
  • AMV564
  • AMV564 in combination with pembrolizumab
  • San Francisco, California
  • +9 more
Oct 11, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Acute Myeloid Leukemia Trial in Seattle (Telephone-Based Intervention, Behavioral, Psychological or Informational Intervention,

Terminated
  • Acute Myeloid Leukemia
  • Telephone-Based Intervention
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2021

Acute Myeloid Leukemia Trial in Worldwide (Azacitidine, IMGN632, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +19 more
May 25, 2021

Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United

Completed
  • Acute Myeloid Leukemia
  • +27 more
  • Caspofungin Acetate
  • +2 more
  • Birmingham, Alabama
  • +178 more
Mar 26, 2021

Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)

Completed
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +18 more
Mar 12, 2021

Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)

Withdrawn
  • Acute Myeloid Leukemia
  • Minimal Residual Disease Negativity
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 27, 2021

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

Completed
  • Acute Myeloid Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
  • +1 more
Sep 9, 2020

Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)

Completed
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +3 more
Apr 3, 2020

Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

Completed
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +80 more
Feb 19, 2020

Acute Myeloid Leukemia Trial in United States (PLX3397)

Completed
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +8 more
Feb 18, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)

Terminated
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
  • +10 more
Feb 12, 2020